Open access
Oct 2026
Cancer-cell-mimicking MnO2 nanoplatform delivers immunological adjuvants to enhance radio-immunotherapy
A tumor cell membrane-mimetic manganese-based nanoplatform for delivering immune adjuvants (MnO2-R848@CM) to synergistically enhance the efficacy of clinical radiotherapy and highlight the potential of the MnO2–R848@CM nanoplatform in advancing synergistic cancer radioimmunotherapy.
Zhen Zhang, Ping Liu, Wei-Ke Zeng et al.
· Materials Today Bio · 0 citations